| Cerebrovascular Accident |
1 |
1 |
| Thromboembolism |
0 |
1 |
| Clinical Guidelines |
0 |
0.91 |
| Cardiac Surgery |
0 |
0.63 |
| Anticoagulation Therapy |
0 |
0.49 |
| Atrial Fibrillation |
0 |
0.33 |
| Foramen |
0 |
0.28 |
| Deep Venous Thrombosis |
0 |
0.2 |
| Food and Drug Administration (FDA) |
0 |
0.16 |
| Pulmonary Embolism |
0 |
0.14 |
| Healthcare and Medical Technology |
0 |
0.12 |
| Ischemic Stroke |
0 |
0.12 |
| Abuse |
0 |
0.08 |
| Clinical Research |
0 |
0.08 |
| Europe |
0 |
0.08 |
| Transient Ischemic Attack |
0 |
0.08 |
| Transplant Evaluation |
0 |
0.08 |
| Aneurysm |
0 |
0.06 |
| Cardiovascular Imaging |
0 |
0.06 |
| Migraine |
0 |
0.06 |
| Angiography |
0 |
0.04 |
| California |
0 |
0.04 |
| Child |
0 |
0.04 |
| Embolism |
0 |
0.04 |
| Hospital |
0 |
0.04 |
| Hypoxia |
0 |
0.04 |
| Interventional Cardiology |
0 |
0.04 |
| New York |
0 |
0.04 |
| Recurrent Stroke |
0 |
0.04 |
| Surgery |
0 |
0.04 |
| Thrombosis |
0 |
0.04 |
| Vein |
0 |
0.04 |